secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2021-08-04T23:59:59+00:00
Accession:  0001193125-21-236343
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Susan Dodson DeVore elected to Anthem board as independent director
-------------------------------------------------------------------

- Elected effective Aug 3, 2021; term expires at 2022 annual meeting; appointed to Audit and Finance Committees.
- DeVore recently retired as CEO and Director of Premier, Inc., a healthcare supply chain and technology company.
- She brings decades of finance, strategy, and healthcare consulting experience, including as a partner at Ernst & Young.
- She also serves on the board of UNUM Group.
- Board Chair Elizabeth Tallett says DeVore's leadership in driving innovation will provide valuable insights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312521236343/0001193125-21-236343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312521236343/d169797d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-236343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer